SANDRENA

This brand name is authorized in Australia, Brazil, UK.

Active ingredients

The drug SANDRENA contains one active pharmaceutical ingredient (API):

1	Estradiol UNII 4TI98Z838E - ESTRADIOL
	Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy.
	Read more about Estradiol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SANDRENA Gel	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03CA03	Estradiol	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03C Estrogens → G03CA Natural and semisynthetic estrogens, plain
Discover more medicines within G03CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8286D
BR	Câmara de Regulação do Mercado de Medicamentos	527303501166318, 527303502162316
GB	Medicines & Healthcare Products Regulatory Agency	36580, 36588, 36590